Ligand validation:5FB9

BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5FB9_BTB_B_601	55%	66%	0.131	0.897	0.87	0.46	1	-	0	0	100%	1
5FB9_BTB_A_601	34%	62%	0.19	0.871	0.87	0.58	-	-	0	0	100%	1
5FBB_BTB_A_1001	78%	54%	0.092	0.933	0.95	0.85	-	-	0	0	100%	1
7QTB_BTB_A_408	70%	63%	0.137	0.955	1	0.42	1	-	0	0	100%	1
7QTA_BTB_B_408	47%	72%	0.172	0.911	0.84	0.27	1	-	0	0	100%	1
5O5D_BTB_A_604	100%	59%	0.022	0.994	0.89	0.68	1	-	2	0	100%	1
9CWK_BTB_B_505	100%	80%	0.025	0.996	0.31	0.53	-	-	2	0	100%	1
9CW6_BTB_C_504	100%	51%	0.028	0.996	0.41	1.45	-	1	4	0	100%	1
9CW4_BTB_C_504	100%	49%	0.032	0.995	0.42	1.5	-	2	2	0	100%	1
8F9X_BTB_J_305	100%	60%	0.032	0.992	0.86	0.66	-	-	5	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.